CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia

por Kaito, Yuta, Hirano, Mitsuhito, Futami, Muneyoshi, Nojima, Masanori, Tamura, Hideto, Tojo, Arinobu, Imai, Yoichi
Publicado 2022

Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

por Kaito, Yuta, Yui, Shunsuke, Inai, Kazuki, Onai, Daishi, Kinoshita, Ryosuke, Yamanaka, Satoshi, Okamoto, Muneo, Wada, Ryuichi, Ohashi, Ryuji, Inokuchi, Koiti, Yamaguchi, Hiroki
Publicado 2021

Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma

por Hirano, Mitsuhito, Imai, Yoichi, Kaito, Yuta, Murayama, Takahiko, Sato, Kota, Ishida, Tadao, Yamamoto, Junichi, Ito, Takumi, Futami, Muneyoshi, Ri, Masaki, Yasui, Hiroshi, Denda, Tamami, Tanaka, Yukihisa, Ota, Yasunori, Nojima, Masanori, Kamikubo, Yasuhiko, Gotoh, Noriko, Iida, Shinsuke, Handa, Hiroshi, Tojo, Arinobu
Publicado 2021

Clinical impact of serum soluble SLAMF7 in multiple myeloma

por Ishibashi, Mariko, Soeda, Saori, Sasaki, Makoto, Handa, Hiroshi, Imai, Yoichi, Tanaka, Norina, Tanosaki, Sakae, Ito, Shigeki, Odajima, Takeshi, Sugimori, Hiroki, Asayama, Toshio, Sunakawa, Mika, Kaito, Yuta, Kinoshita, Ryosuke, Kuribayashi, Yasuko, Onodera, Asaka, Moriya, Keiichi, Tanaka, Junji, Tsukune, Yutaka, Komatsu, Norio, Inokuchi, Koiti, Tamura, Hideto
Publicado 2018